Gese Biotechnology

Guangzhou Gese Biotechnology Co., Ltd. was established in June 2010, located in Guangzhou Science City High-tech Industrial Development Zone. It is a high-tech enterprise focusing on circRNA product development and services, mainly engaged in the research and development of circRNA-based disease diagnostic markers. As an important part of human information transmission, RNA detection has not attracted sufficient attention. The emergence of circRNA has been hailed as a major research achievement at the level of rewriting textbooks. Numerous studies have shown that circRNA is closely related to the occurrence and development of diseases including cancer, coronary artery disease, and neurodegenerative diseases, and can serve as an ideal diagnostic marker for diseases.
Since 2014, the Gese team has focused on the niche field of circRNA. After five years of unremitting efforts, they have obtained 5 national invention authorized patents, 6 national computer software copyrights, 3 national invention patents applied and accepted, and 5 high-tech products of Guangdong Province. They have solved a series of scientific bottlenecks such as difficulty in circRNA detection and functional research, and transformed core technologies into market demands. With the explosive growth of the liquid biopsy market, there is a huge demand for upstream extraction and purification products, which has been monopolized by foreign biotechnology giants. Gese's subsidiary, Atcgene, focuses on the development of upstream extraction and purification products for liquid biopsy, providing high-quality and cost-effective nucleic acid extraction products for the liquid biopsy market. As the company's brand academic activity, the "circRNA Research Forum" has been successfully held for five sessions, bringing together the most influential industry experts at home and abroad, arousing strong attention in the industry, promoting scientific research development and achievement implementation, and continuously leading industry development.
In the future, Gese people, driven by independent research and development and the transformation of scientific research achievements, based in China's biomedical health field, with the concept of "prevention before cancer", and with the vision of developing Chinese original cancer early screening products, are committed to the development of products for early diagnosis of human diseases and personalized medical health diagnosis and treatment, creating a well-known brand in China's biomedical industry.